Cancer Drugs Market

Global Cancer Drugs Market Size, Trends & Analysis - Forecasts to 2028 By Type (Chemotherapy, Targeted Therapy, Immunotherapy and Hormonal Therapy), By Application (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Cervical Cancer, and Other Cancers), By Region (North America, Asia Pacific, Central and South America, Europe, the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on May 1 2024 with the latest and most recent market numbers

Global Cancer Drugs Market Size

The global cancer drugs market is projected to grow at a CAGR of 11.6% from 2023 to 2028. Cancer is a serious and complex disease that has posed significant challenges in terms of effective treatment. Medical professionals have been working hard to develop new research methods to tackle this disease. The entire medical research community has prioritized cancer research to discover innovative treatments and analyse new techniques for treatment.

The cancer drug market is primarily driven by factors such as increasing cancer cases, rapid advancements in cancer research and development, rising healthcare spending on cancer research, increasing patient awareness and demand for high end treatment, rapidly growing population clubbed with advancement in cancer supportive care.

The rise in the global incidence of cancer has led to a corresponding increase in the utilization of drugs such as morphine, fentanyl, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and others for managing cancer-related pain in patients with lung cancer, bone cancer, and other forms of cancer. Consequently, there has been a significant surge in the expenditure on medications to alleviate the distress caused by cancer. As the prevalence of cancer continues to rise, it is expected that the market for these medications will experience further growth. The increasing number of new cancer cases diagnosed worldwide has contributed to this expectation.

The continuous investment in cancer research and development has resulted in discovery of innovative drugs and treatment approaches. Newer targeted therapies, immunotherapies, and personalized medicine have improved treatment outcomes and expanded the options available for cancer patients.

There has been a notable shift in focus towards the healthcare sector by both the government and private industries. The heightened focus on the healthcare sector has led to a notable increase in investments within the market. Pharmaceutical companies are specifically increasing their investments in the research and development of new cancer drugs, which is expected to create favourable prospects for growth in the coming years.

Another contributing factor to the growth of the cancer drug market is the growing awareness about cancer, early detection, and the availability of effective treatment options. The increased awareness has resulted in a greater demand for cancer drugs from patients and their families. They actively seek out advanced treatment options and are willing to invest in newer therapies that have the potential to be more effective in combating the disease.

As per the World Health Organization (WHO), the rate of population aging is accelerating at a faster pace than before. In 2020, the number of individuals aged 60 and above surpassed the number of children under 5. The proportion of the global population aged 60 years and older is projected to nearly double from 12% to 22% between 2015 and 2050. Considering that cancer is more commonly observed in older individuals, the expanding elderly population is anticipated to drive an increased need for cancer drugs.

Apart from the primary treatment of cancer, there is an increasing focus on providing supportive care to cancer patients. This involves the use of medications that help manage symptoms, alleviate treatment side effects, and enhance the overall quality of life for patients. The demand for supportive care drugs is projected to rise, thereby contributing to the overall expansion of the cancer drug market.

global cancer drugs market

Global Cancer Drugs Market: By Drug Class Type

The targeted therapy is expected to witness the largest share in the global cancer drug market during the forecast period of 2023-2028. The segment of targeted therapy is the leading contributor to the market's growth because it specifically targets the proteins involved in the development of tumors, focusing on unique molecular changes that are specific to each type of cancer. This approach offers benefits such as fewer adverse effects compared to traditional treatments.

The immunotherapy segment is expected to be the fastest growing segment in the global market. This is primarily driven by the increasing recognition of the advantages linked to the utilization of monoclonal antibodies in cancer immunotherapy. Consequently, there is a growing acceptance and adoption of immunotherapy among the general population.

Global Cancer Drugs Market: By Application

Lung’s cancer caused the highest number of deaths till 2021, it is the fastest growing segment, its incidence rate among both men and women, with an estimated 2.2 million cases, with largest revenue generation.

Whereas breast cancer is the opportunistic segment for cancer drug market as it will be the fastest growing segment. Based on World Health Organization (WHO) data, breast cancer is the most detected cancer in women globally, with around 2.3 million new cases reported in 2020. Additionally, prostate cancer, liver cancer, and several other types of cancer contribute to the overall burden of cancer.

asia pacific cancer drugs market

Global Cancer Drugs Market: By Region

The cancer drug market is anticipated to be predominantly led by the North American segment. Cancer is the leading cause of death in Canada, with prostate cancer being the most commonly diagnosed cancer among males and breast cancer among females. However, regardless of gender, lung cancer remains the main cause of cancer-related deaths. This emphasizes the substantial impact of cancer on the population and highlight the urgent requirement for the development of efficient drugs and treatments to combat these diseases.

In terms of growth, the Asia-Pacific region is projected to witness the fastest expansion in the global market. Developing countries in this region are experiencing notable advancements in healthcare infrastructure, including the establishment of hospitals, clinics, and specialized cancer centers. This development has resulted in improved accessibility to cancer treatments and medications, thereby driving the growth of the market in these regions.

Global Cancer Drugs Market Share and Competitor Analysis

F. Hoffmann-La Roche Ltd, Genentech, Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and, Company, AstraZeneca, Sanofi, and Bayer AG among others, are some of the key players in global cancer drug market.

Please note: This is not an exhaustive list of companies profiled in the report.

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

2.4 Data Metrics

3 GLOBAL CANCER DRUGS MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL CANCER DRUGS MARKET, BY DRUG CLASS TYPE

4.1 Introduction

4.2 Cancer Drugs Market: Drug class type Scope Key Takeaways

4.3 Revenue Growth Analysis, 2022 & 2028

4.4 Chemotherapy

4.4.1 Chemotherapy Market Estimates and Forecast, 2020-2028 (USD Billion)

4.5 Targeted Therapy

4.5.1 Targeted Therapy Market Estimates and Forecast, 2020-2028 (USD Billion)

4.6 Immunotherapy Therapy

4.6.1 Immunotherapy Therapy Market Estimates and Forecast, 2020-2028 (USD Billion)

4.7 Hormonal Therapy

4.7.1 Hormonal Therapy Market Estimates and Forecast, 2020-2028 (USD Billion)

5 GLOBAL CANCER DRUGS MARKET, BY APPLICATION

5.1 Introduction

5.2 Cancer Drugs Market: Application Scope Key Takeaways

5.3 Revenue Growth Analysis, 2022 & 2028

5.4 Lung Cancer

5.4.1 Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

5.5 Breast Cancer

5.5.1 Breast Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

5.6 Prostate Cancer

5.6.1 Prostate Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

5.7 Liver Cancer

5.7.1 Liver Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

5.8 Cervical Cancer

5.8.1 Cervical Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

5.9 Other Cancer

5.9.1 Other Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)

6 GLOBAL CANCER DRUGS MARKET, BY REGION

6.1 Introduction

6.2 North America Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.2.1 By Drug class type

6.2.2 By Application

6.2.3 By Country

6.2.3.1 U.S. Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.2.3.1.1 By Drug class type

6.2.3.1.2 By Application

6.2.3.2 Canada Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.2.3.2.1 By Drug class type

6.2.3.2.2 By Application

6.2.3.3 Mexico Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.2.3.3.1 By Drug class type

6.2.3.3.2 By Application

6.3 Europe Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.1 By Drug class type

6.3.2 By Application

6.3.3 By Country

6.3.3.1 Germany Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.1.1 By Drug class type

6.3.3.1.2 By Application

6.3.3.2 U.K. Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.2.1 By Drug class type

6.3.3.2.2 By Application

6.3.3.3 France Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.3.1 By Drug class type

6.3.3.3.2 By Application

6.3.3.4 Italy Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.4.1 By Drug class type

6.3.3.4.2 By Application

6.3.3.5 Spain Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.5.1 By Drug class type

6.3.3.5.2 By Application

6.3.3.6 Netherlands Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.6.1 By Drug class type

6.3.3.6.2 By Application

6.3.3.7 Rest of Europe Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.3.3.7.1 By Drug class type

6.3.3.7.2 By Application

6.4 Asia Pacific Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.1 By Drug class type

6.4.2 By Application

6.4.3 By Country

6.4.3.1 China Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.1.1 By Drug class type

6.4.3.1.2 By Application

6.4.3.2 Japan Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.2.1 By Drug class type

6.4.3.2.2 By Application

6.4.3.3 India Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.3.1 By Drug class type

6.4.3.3.2 By Application

6.4.3.4 South Korea Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.4.1 By Drug class type

6.4.3.4.2 By Application

6.4.3.5 Singapore Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.5.1 By Drug class type

6.4.3.5.2 By Application

6.4.3.6 Malaysia Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.6.1 By Drug class type

6.4.3.6.2 By Application

6.4.3.7 Thailand Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.7.1 By Drug class type

6.4.3.7.2 By Application

6.4.3.8 Indonesia Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.8.1 By Drug class type

6.4.3.8.2 By Application

6.4.3.9 Vietnam Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.9.1 By Drug class type

6.4.3.9.2 By Application

6.4.3.10 Taiwan Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.10.1 By Drug class type

6.4.3.10.2 By Application

6.4.3.11 Rest of Asia Pacific Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.4.3.11.1 By Drug class type

6.4.3.11.2 By Application

6.5 Middle East & Africa Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.1 By Drug class type

6.5.2 By Application

6.5.4 By Country

6.5.3.1 Saudi Arabia Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.3.1.1 By Drug class type

6.5.3.1.2 By Application

6.5.3.2 U.A.E. Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.3.2.1 By Drug class type

6.5.3.2.2 By Application

6.5.3.3 Israel Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.3.3.1 By Drug class type

6.5.3.3.2 By Application

6.5.3.4 South Africa Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.3.4.1 By Drug class type

6.5.3.4.2 By Application

6.5.3.5 Rest of Middle East & Africa Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.5.3.5.1 By Drug class type

6.5.3.5.2 By Application

6.6 Central & South America Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6.1 By Drug class type

6.6.2 By Application

6.6.3 By Country

6.6.3.1 Brazil Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6.3.1.1 By Drug class type

6.6.3.1.2 By Application

6.6.3.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6.3.2.1 By Drug class type

6.6.3.2.2 By Application

6.6.3.3 Chile Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6.3.3.1 By Drug class type

6.6.3.3.2 By Application

6.6.3.4 Rest of Central & South America Cancer Drugs Market Estimates and Forecast, 2020-2028 (USD Billion)

6.6.3.4.1 By Drug class type

6.6.3.4.2 By Application

7 COMPETITIVE LANDCAPE

7.1 Company Market Share Analysis

7.2 Four Quadrant Positioning Matrix

7.2.1 Market Leaders

7.2.2 Market Visionaries

7.2.3 Market Challengers

7.2.4 Niche Market Players

7.3.4 Rest of the World

7.4 Company Profiles

7.4.1 F. Hoffmann-La Roche Ltd

7.4.1.1 Business Description & Financial Analysis

7.4.1.2 SWOT Analysis

7.4.1.3 Products & Services Offered

7.4.1.4 Strategic Alliances between Business Partners

7.4.2 Genentech, Inc.

7.4.2.1 Business Description & Financial Analysis

7.4.2.2 SWOT Analysis

7.4.2.3 Products & Services Offered

7.4.2.4 Strategic Alliances between Business Partners

7.4.3 Novartis AG

7.4.3.1 Business Description & Financial Analysis

7.4.3.2 SWOT Analysis

7.4.3.3 Products & Services Offered

7.4.3.4 Strategic Alliances between Business Partners

7.4.3 Pfizer Inc.

7.4.3.1 Business Description & Financial Analysis

7.4.3.2 SWOT Analysis

7.4.3.3 Products & Services Offered

7.4.3.4 Strategic Alliances between Business Partners

7.4.5 Bristol-Myers Squibb Company

7.4.5.1 Business Description & Financial Analysis

7.4.5.2 SWOT Analysis

7.4.5.3 Products & Services Offered

7.4.5.4 Strategic Alliances between Business Partners

7.4.6 GLAXOSMITHKLINE PLC.

7.4.6.1 Business Description & Financial Analysis

7.4.6.2 SWOT Analysis

7.4.6.3 Products & Services Offered

7.4.6.4 Strategic Alliances between Business Partners

7.4.7 Eli Lilly and, Company

7.4.7.1 Business Description & Financial Analysis

7.4.7.2 SWOT Analysis

7.4.7.3 Products & Services Offered

7.4.8.4 Strategic Alliances between Business Partners

7.4.8 AstraZeneca

7.4.8.1 Business Description & Financial Analysis

7.4.8.2 SWOT Analysis

7.4.8.3 Products & Services Offered

7.4.8.4 Strategic Alliances between Business Partners

7.4.9 Klein Tools Inc.

7.4.9.1 Business Description & Financial Analysis

7.4.9.2 SWOT Analysis

7.4.9.3 Products & Services Offered

7.4.9.4 Strategic Alliances between Business Partners

7.4.10 Bayer AG

7.4.10.1 Business Description & Financial Analysis

7.4.10.2 SWOT Analysis

7.4.10.3 Products & Services Offered

7.4.10.4 Strategic Alliances between Business Partners

8 RESEARCH METHODOLOGY

8.1 Market Introduction

8.1.1 Market Definition

8.1.2 Market Scope & Segmentation

8.2 Information Procurement

8.2.1 Secondary Research

8.2.1.1 Purchased Databases

8.2.1.2 GMEs Internal Data Repository

8.2.1.3 Secondary Resources & Third Party Perspectives

8.2.1.4 Company Information Sources

8.2.2 Primary Research

8.2.2.1 Various Type of Respondents for Primary Interviews

8.2.2.2 Number of Interviews Conducted throughout the Research Process

8.2.2.3 Primary Stakeholders

8.2.2.4 Discussion Guide for Primary Participants

8.2.3 Expert Panels

8.2.3.1 Expert Panels Across 30+ Industry

8.2.4 Paid Local Experts

8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

8.3 Market Estimation

8.3.1 Top-Down Approach

8.3.1.1 Macro-Economic Indicators Considered

8.3.1.2 Micro-Economic Indicators Considered

8.3.2 Bottom Up Approach

8.3.2.1 Company Share Analysis Approach

8.3.2.2 Estimation of Potential Product Sales

8.4 Data Triangulation

8.4.1 Data Collection

8.4.2 Time Series, Cross Sectional & Panel Data Analysis

8.4.3 Cluster Analysis

8.5 Analysis and Output

8.5.1 Inhouse AI Based Real Time Analytics Tool

8.5.2 Output From Desk & Primary Research

8.6 Research Assumptions & Limitations

8.7.1 Research Assumptions

8.7.2 Research Limitations

LIST OF TABLES

1 Global Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

2 Chemotherapy Market, By Region, 2020-2028 (USD Billion)

3 Targeted Therapy Market, By Region, 2020-2028 (USD Billion)

4 Immunotherapy Therapy Market, By Region, 2020-2028 (USD Billion)

5 Hormonal Therapy Market, By Region, 2020-2028 (USD Billion)

6 Global Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

7 Lung Cancer Market, By Region, 2020-2028 (USD Billion)

8 Breast Cancer Market, By Region, 2020-2028 (USD Billion)

9 Prostate Cancer Market, By Region, 2020-2028 (USD Billion)

10 Liver Cancer Market, By Region, 2020-2028 (USD Billion)

11 Cervical Cancer Market, By Region, 2020-2028 (USD Billion)

12 Other Cancer Market, By Region, 2020-2028 (USD Billion)

13 Regional Analysis, 2020-2028 (USD Billion)

14 North America Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

15 North America Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

16 North America Cancer Drugs Market, By Country, 2020-2028 (USD Billion)

17 U.S Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

18 U.S Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

19 Canada Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

20 Canada Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

21 Mexico Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

22 Mexico Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

23 Europe Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

24 Europe Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

25 Germany Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

26 Germany Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

27 UK Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

28 UK Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

29 France Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

30 France Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

31 Italy Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

32 Italy Cancer Drugs Market, By application, 2020-2028 (USD Billion)

33 Spain Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

34 Spain Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

35 Rest Of Europe Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

36 Rest Of Europe Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

37 Asia Pacific Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

38 Asia Pacific Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

39 Asia Pacific Cancer Drugs Market, By Country, 2020-2028 (USD Billion)

40 China Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

41 China Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

42 India Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

43 India Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

44 Japan Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

45 Japan Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

46 South Korea Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

47 South Korea Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

48 Middle East & Africa Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

49 Middle East & Africa Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

50 Middle East & Africa Cancer Drugs Market, By Country, 2020-2028 (USD Billion)

51 Saudi Arabia Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

52 Saudi Arabia Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

53 UAE Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

54 UAE Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

55 Central & South America Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

56 Central & South America Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

57 Central & South America Cancer Drugs Market, By Country, 2020-2028 (USD Billion)

58 Brazil Cancer Drugs Market, By Drug class type, 2020-2028 (USD Billion)

59 Brazil Cancer Drugs Market, By Application , 2020-2028 (USD Billion)

60 F. Hoffmann-La Roche Ltd: Products & Services Offering

61 Genentech, Inc.: Products & Services Offering

62 Novartis AG: Products & Services Offering

63 Pfizer Inc.: Products & Services Offering

64 Bristol-Myers Squibb Company: Products & Services Offering

65 GLAXOSMITHKLINE PLC.: Products & Services Offering

66 Eli Lilly and, Company : Products & Services Offering

67 AstraZeneca: Products & Services Offering

68 Sanofi: Products & Services Offering

69 Bayer AG: Products & Services Offering

LIST OF FIGURES

1 Global Cancer Drugs Market Overview

2 Global Cancer Drugs Market Value From 2020-2028 (USD Billion)

3 Global Cancer Drugs Market Share, By Drug class type (2022)

4 Global Cancer Drugs Market Share, By Application (2022)

5 Global Cancer Drugs Market, By Region (Asia Pacific Market)

6 Technological Trends In Global Cancer Drugs Market

7 Four Quadrant Competitor Positioning Matrix

8 Impact Of Macro & Micro Indicators On The Market

9 Impact Of Key Drivers On The Global Cancer Drugs Market

10 Impact Of Challenges On The Global Cancer Drugs Market

11 Porter’s Five Forces Analysis

12 Global Cancer Drugs Market: By Drug class type Scope Key Takeaways

13 Global Cancer Drugs Market, By Drug class type Segment: Revenue Growth Analysis

14 Chemotherapy Market, By Region, 2020-2028 (USD Billion)

15 Targeted Therapy Market, By Region, 2020-2028 (USD Billion)

16 Immunotherapy Therapy Market, By Region, 2020-2028 (USD Billion)

17 Hormonal Therapy Market, By Region, 2020-2028 (USD Billion)

18 Global Cancer Drugs Market: By Application Scope Key Takeaways

19 Global Cancer Drugs Market, By Application Segment: Revenue Growth Analysis

20 Lung Cancer Market, By Region, 2020-2028 (USD Billion)

21 Breast Cancer Market, By Region, 2020-2028 (USD Billion)

22 Prostate Cancer Market, By Region, 2020-2028 (USD Billion)

23 Liver Cancer Market, By Region, 2020-2028 (USD Billion)

24 Cervical Cancer Market, By Region, 2020-2028 (USD Billion)

25 Other Cancer Market, By Region, 2020-2028 (USD Billion)

26 Global Cancer Drugs Market: Regional Analysis

27 North America Cancer Drugs Market Overview

28 North America Cancer Drugs Market, By Drug class type

29 North America Cancer Drugs Market, By Application

30 North America Cancer Drugs Market, By Country

31 U.S. Cancer Drugs Market, By Drug class type

32 U.S. Cancer Drugs Market, By Application

33 Canada Cancer Drugs Market, By Drug class type

34 Canada Cancer Drugs Market, By Application

35 Mexico Cancer Drugs Market, By Drug class type

36 Mexico Cancer Drugs Market, By Application

37 Four Quadrant Positioning Matrix

38 Company Market Share Analysis

39 F. Hoffmann-La Roche Ltd: Company Snapshot

40 F. Hoffmann-La Roche Ltd: SWOT Analysis

41 F. Hoffmann-La Roche Ltd: Geographic Presence

42 Genentech, Inc.: Company Snapshot

43 Genentech, Inc.: SWOT Analysis

44 Genentech, Inc.: Geographic Presence

45 Novartis AG: Company Snapshot

46 Novartis AG: SWOT Analysis

47 Novartis AG: Geographic Presence

48 Pfizer Inc.: Company Snapshot

49 Pfizer Inc.: Swot Analysis

50 Pfizer Inc.: Geographic Presence

51 Bristol-Myers Squibb Company: Company Snapshot

52 Bristol-Myers Squibb Company: SWOT Analysis

53 Bristol-Myers Squibb Company: Geographic Presence

54 GLAXOSMITHKLINE PLC.: Company Snapshot

55 GLAXOSMITHKLINE PLC.: SWOT Analysis

56 GLAXOSMITHKLINE PLC.: Geographic Presence

57 Eli Lilly and, Company : Company Snapshot

58 Eli Lilly and, Company : SWOT Analysis

59 Eli Lilly and, Company : Geographic Presence

60 AstraZeneca: Company Snapshot

61 AstraZeneca: SWOT Analysis

62 AstraZeneca: Geographic Presence

63 Sanofi.: Company Snapshot

64 Sanofi.: SWOT Analysis

65 Sanofi.: Geographic Presence

66 Bayer AG: Company Snapshot

67 Bayer AG: SWOT Analysis

68 Bayer AG: Geographic Presence

The Global Cancer Drugs Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cancer Drugs Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the cancer drugs market?

The global cancer drugs market is projected to grow at a CAGR of 11.6% from 2023 to 2028.

Who are the major vendors in the cancer drugs market?

What are the opportunities prevailing in the global cancer drugs market?

The global cancer drugs market presents significant opportunities for growth and innovation. Advances in targeted therapies, immunotherapies, and precision medicine have expanded treatment options. Additionally, rising incidence rates of cancer and increasing investments in research and development create a favourable environment for developing and commercializing new cancer drugs.

What are the major drivers in the cancer drugs market?

The growth of the cancer drug market is propelled by several factors, including the rising incidence of cancer, continuous advancements in cancer research, increased healthcare expenditure on cancer-related initiatives, growing patient awareness and demand for advanced treatments, and improved cancer supportive care, driven by a rapidly expanding population.